Literature DB >> 22480621

Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited.

Stephen W Schaffer1, Chian Ju Jong, Mahmood Mozaffari.   

Abstract

Oxidative stress is recognized as a key participant in the development of diabetic complications in the vasculature. One of the seminal studies advancing the role of oxidative stress in vascular endothelial cells proposed that oxidative stress-mediated diversion of glycolytic intermediates into pathological pathways was a key underlying element in the development of diabetic complications. It is widely recognized that flux through glycolysis slows during diabetes. However, several bottlenecks develop in the glycolytic pathway, including glucose transport, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase. Of these limiting steps in glycolysis, glyceraldehyde-3-phosphate dehydrogenase is most sensitive to oxidative stress, leading to the hypothesis that glyceraldehyde-3-phosphate inactivation by ribosylation underlies the diversion of glycolytic intermediates into pathological pathways. However, recent studies question the mechanism underlying the effect of reactive oxygen species on key enzymes of the glycolytic pathway. The present review critiques the major premises of the hypothesis and concludes that further study of the role of oxidative stress in the development of diabetes-mediated vasculature dysfunction is warranted.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480621     DOI: 10.1016/j.vph.2012.03.005

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  42 in total

Review 1.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 2.  Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

Review 3.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 4.  Metabolic syndrome, aging and involvement of oxidative stress.

Authors:  Francesca Bonomini; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

5.  mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-03-15

Review 6.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.

Authors:  Manasi S Shah; Michael Brownlee
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

Review 7.  Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?

Authors:  Sih Min Tan; Judy B de Haan
Journal:  Redox Rep       Date:  2014-02-21       Impact factor: 4.412

Review 8.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 9.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

10.  Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.

Authors:  A M D Watson; M Olukman; C Koulis; Y Tu; D Samijono; D Yuen; C Lee; D J Behm; M E Cooper; K A M Jandeleit-Dahm; A C Calkin; T J Allen
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.